In early 2026, Artificial Intelligence (AI) has transitioned from a research tool to the primary engine for biomarker discovery. These "learning algorithms" are now capable of scanning billions of data points from electronic health records and biobanks to identify subtle "biomarker signatures" that were previously invisible to human researchers. The most exciting development is the rise of...

Biomarkers Market Summary The global biomarkers market size was estimated at USD 81.04 billion in 2023 and is projected to reach USD 194.21 billion by 2030, growing at a CAGR of 13.36% from 2024 to 2030. The growth of this market is primarily driven by the rising prevalence of cancer and other chronic diseases, the increasing significance of companion diagnostics, growing investments...

Biomarkers Market Summary The global biomarkers market size was estimated at USD 81.04 billion in 2023 and is projected to reach USD 194.21 billion by 2030, growing at a CAGR of 13.36% from 2024 to 2030. The growth of this market is primarily driven by the rising prevalence of cancer and other chronic diseases, the increasing significance of companion diagnostics, growing investments...

“According to a new report published by Introspective Market Research, Biomarkers Market by Type, Application, and End User, The Global Biomarkers Market Size Was Valued at USD 80.04 Billion in 2023 and is Projected to Reach USD 278.6 Billion by 2032, Growing at a CAGR of 13.36% from 2024–2032.” The biomarkers market plays a pivotal role in modern healthcare by enabling early...

In 2026, the biomarkers market is witnessing a massive expansion into "Digital Biomarkers"—physiological data collected 24/7 by smartwatches and medical-grade wearables. In 2026, the market is identifying "Digital Monitoring" as a breakout category, projected to reach over $5 billion as doctors use continuous heart rate, sleep, and glucose data to manage chronic diseases. This 2026...

"Regional Overview of Executive Summary China Cancer Biomarkers Market by Size and Share CAGR Value The China cancer biomarker market is experiencing significant growth, driven by increasing cancer incidence rates, advancements in biomarker-based diagnostics, and rising demand for personalized medicine. The market is supported by government initiatives promoting early detection and...

"Executive Summary Europe Cancer Biomarkers Market Size and Share Forecast CAGR Value Data Bridge Market Research analyses that the cancer biomarkers market which was USD 4.15 billion in 2022, would rocket up to USD 9.56 billion by 2030, and is expected to undergo a CAGR of 11.0% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market...

Rapid developments in the Brain Biomarkers Market are establishing it as an essential segment in neurology and precision medicine. Biomarkers—biological molecules indicating normal or pathological brain functions—are increasingly applied for early diagnosis, monitoring, and treatment decision-making, especially for neurodegenerative disorders such as Alzheimer’s,...

"What’s Fueling Executive Summary North America Biomarkers Market Size and Share Growth CAGR Value  Data Bridge Market Research analyses the market to grow at a CAGR of 6.5% in the above-mentioned forecast period. An influential North America Biomarkers Market document supports in achieving a sustainable growth in the market, by providing a well-versed, specific and most...

According to a new report published by Introspective Market Research, Renal Biomarkers Market by Biomarker Type (Functional Biomarkers, Up-regulated Proteins, Others), Diagnostic Technique (ELISA, PETIA, Colorimetric Assay, CLIA, Others), and End User (Hospitals, Diagnostic Laboratories, Academic & Research Institutes), The Global Renal Biomarkers Market Size Was Valued at USD 1.5...